Bausch + Lomb Corporation BLCO.TO
BLCO.TO Rating
BLCO.TO Rating Factors
BLCO.TO Company Overview
Bausch + Lomb Corporation is a global eye health company focused on vision care, ophthalmic pharmaceuticals, surgical products, and consumer eye health solutions. The company operates across the broader healthcare and medical technology industries, serving patients, eye care professionals, hospitals, ambulatory surgery centers, and retail consumers. Its primary revenue drivers include contact lenses, lens care products, prescription ophthalmic medicines, over-the-counter eye care products, cataract surgery equipment, and vitreoretinal surgical systems. The company competes with other major ophthalmology and vision care firms through a diversified product portfolio spanning both medical devices and pharmaceuticals.
The company traces its origins to 1853 when it was founded in Rochester, New York by John Jacob Bausch and Henry Lomb. Over time, it evolved from an optical goods manufacturer into a diversified eye health company with global operations. Bausch + Lomb underwent multiple ownership changes, including acquisition by Valeant Pharmaceuticals (later renamed Bausch Health Companies). In 2022, Bausch + Lomb Corporation returned to the public markets through an initial public offering while maintaining operational ties to Bausch Health. The company positions itself through broad product diversification, established ophthalmology relationships, a large international distribution footprint, and a recognized brand in eye care supported by product development and regulatory expertise.
BLCO.TO Income Statement
BLCO.TO Balance Sheet
BLCO.TO Price History
BLCO.TO Valuation
BLCO.TO Dividends and Shares
BLCO.TO Corporate Info
Vaughan, ON L4K 4B4